Evidence map›Paper›PMID 30866492›Full record

ReviewCancers2019

The Enigmatic HOX Genes: Can We Crack Their Code?

Zhifei Luo, Suhn K Rhie, Peggy J Farnham

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Genes · 2024
    Article
  11. Review
  12. Absence of the RING domain inLife science alliance · 2024
    Article
  13. Article
  14. HOXA9 Regulome and Pharmacological Interventions in Leukemia.Advances in experimental medicine and biology · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zhifei LuoDepartment of Biochemistry and Molecular Medicine and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA. zhifeilu@usc.edu.
Suhn K RhieDepartment of Biochemistry and Molecular Medicine and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA. rhie@usc.edu.ORCID 0000-0002-5522-5296
Peggy J FarnhamDepartment of Biochemistry and Molecular Medicine and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA. peggy.farnham@med.usc.edu.ORCID 0000-0003-4469-7914
University of Southern California · US

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI William Dean Wallace · 1985 to 2026
$181.4M
Prostate Cancer Risk EnhancersR01CA136924 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI COETZEE, GERHARD A, FARNHAM, PEGGY J · 2010 to 2019
$5.4M
Development of a novel promoter tagging technology to identify enhancer targetsR21HG009742 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI FARNHAM, PEGGY J · 2017 to 2018
$660k
Identification and Clinical Validation of Key Transcription Factor Isoforms Linked to Breast and Prostate Cancer Subgroups using Epigenetic TraitsK01CA229995 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RHIE, SUHN KYONG · 2018 to 2020
$637k
NCI NIH HHS K01 CA229995NCI NIH HHS K01CA229995NCI NIH HHS P30CA014089NCI NIH HHS R01 CA136924NCI NIH HHS R01CA136924NHGRI NIH HHS R21 HG009742
6 · The paper itself

Abstract

Homeobox genes (HOX) are a large family of transcription factors that direct the formation of many body structures during early embryonic development. There are 39 genes in the subgroup of homeobox genes that constitute the human HOX gene family. Correct embryonic development of flies and vertebrates is, in part, mediated by the unique and highly regulated expression pattern of the HOX genes. Disruptions in these fine-tuned regulatory mechanisms can lead to developmental problems and to human diseases such as cancer. Unfortunately, the molecular mechanisms of action of the HOX family of transcription factors are severely under-studied, likely due to idiosyncratic details of their structure, expression, and function. We suggest that a concerted and collaborative effort to identify interacting protein partners, produce genome-wide binding profiles, and develop HOX network inhibitors in a variety of human cell types will lead to a deeper understanding of human development and disease. Within, we review the technological challenges and possible approaches needed to achieve this goal.

Indexed as

cancer biomarkersChIP-seqHOXtargeted therapy

Identifiers

PMID30866492
PMCPMC6468460
OpenAlexW2918502945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.